Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized Open-Label Trial of Levetiracetam for Prevention of Seizures in Patients With Brain Metastases in Primary Motor Cortex

NCT07130786 is registered in ClinicalTrials.gov with Ayal A. Aizer, MD as lead sponsor.

NCT NCT07130786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07130786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized Open-Label Trial of Levetiracetam for Prevention of Seizures in Patients With Brain Metastases in Primary Motor Cortex
Lead sponsor
Ayal A. Aizer, MD
Phase
Phase 2
Overall status
Recruiting
Start date
December 23, 2025
Completion date
February 28, 2030
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from extra-cranial solid tumors, brain metastases from non-small cell lung cancer (nsclc), brain metastases, adult, primary motor cortex, seizures